A biochemical fluorometric method for assessing the oxidative properties of HDL

被引：70

作者：

Kelesidis, Theodoros ^{[1
]}

Currier, Judith S. ^{[1
]}

Huynh, Diana ^{[1
]}

Meriwether, David ^{[2
]}

Charles-Schoeman, Christina ^{[1
]}

Reddy, Srinivasa T. ^{[1
,2
,3
]}

Fogelman, Alan M. ^{[1
]}

Navab, Mohamad ^{[1
]}

Yang, Otto O. ^{[1
,4
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA

[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA

[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA

来源：

JOURNAL OF LIPID RESEARCH | 2011年 / 52卷 / 12期

基金：

美国国家卫生研究院;

关键词：

dysfunctional high density lipoprotein; oxidation; dihydrorhodamine; 123; HDL function; HIGH-DENSITY-LIPOPROTEIN; PEROXYNITRITE-MEDIATED OXIDATION; APOLIPOPROTEIN-A-I; ANTIINFLAMMATORY PROPERTIES; INFLAMMATORY PROPERTIES; METHIONINE SULFOXIDE; LIPID HYDROPEROXIDES; CHOLESTEROL LEVELS; INHIBITS; PLASMA;

D O I：

10.1194/jlr.D018937

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

070307 [化学生物学]; 071010 [生物化学与分子生物学];

摘要：

Most current assays of HDL functional properties are cell-based. We have developed a fluorometric biochemical assay based on the oxidation of dihydrorhodamine 123 (DHR) by HDL. This cell-free assay assesses the intrinsic ability of HDL to be oxidized by measuring increasing fluorescence due to DHR oxidation over time. The assay distinguishes the oxidative potential of HDL taken from different persons, and the results are reproducible. Direct comparison of this measurement correlated well with results obtained using a validated cell-based assay (r(2) = 0.62, P < 0.001). The assay can be scaled from a 96-well format to a 384-well format and, therefore, is suitable for high-throughput implementation. This new fluorometric method offers an inexpensive, accurate, and rapid means for determining the oxidative properties of HDL that is applicable to large-scale clinical studies.-Kelesidis, T., J. S. Currier, D. Huynh, D. Meriwether, C. Charles-Schoeman, S. T. Reddy, A. M. Fogelman, M. Navab, and O. O. Yang. A biochemical fluorometric method for assessing the oxidative properties of HDL. J. Lipid Res. 2011. 52: 2341-2351.

引用

页码：2341 / 2351

页数：11

共 43 条

[1]

ANANTHARAMAIAH GM, 1988, J LIPID RES, V29, P309

[2]

The paradox of dysfunctional high-density lipoprotein [J].

Ansell, Benjamin J. ;

Fonarow, Gregg C. ;

Fogelman, Alan M. .

CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (04) :427-434

[3]

Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment [J].

Ansell, BJ ;

Navab, M ;

Hama, S ;

Kamranpour, N ;

Fonarow, G ;

Hough, G ;

Rahmani, S ;

Mottahedeh, R ;

Dave, R ;

Reddy, ST ;

Fogelman, AM .

CIRCULATION, 2003, 108 (22) :2751-2756

[4]

Antiinflammatory properties of HDL [J].

Barter, PJ ;

Nicholls, S ;

Rye, KA ;

Anantharamaiah, GM ;

Navab, M ;

Fogelman, AM .

CIRCULATION RESEARCH, 2004, 95 (08) :764-772

[5]

HIGH-DENSITY-LIPOPROTEIN IS THE MAJOR CARRIER OF LIPID HYDROPEROXIDES IN HUMAN BLOOD-PLASMA FROM FASTING DONORS [J].

BOWRY, VW ;

STANLEY, KK ;

STOCKER, R .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10316-10320

[6]

Charles-Schoeman C, 2007, J RHEUMATOL, V34, P1459

[7]

Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[8]

MYELOPEROXIDASE, A CATALYST FOR LIPOPROTEIN OXIDATION, IS EXPRESSED IN HUMAN ATHEROSCLEROTIC LESIONS [J].

DAUGHERTY, A ;

DUNN, JL ;

RATERI, DL ;

HEINECKE, JW .

JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) :437-444

[9]

Labile plasma iron in iron overload: redox activity and susceptibility to chelation [J].

Esposito, BP ;

Breuer, W ;

Sirankapracha, P ;

Pootrakul, P ;

Hershko, C ;

Cabantchik, ZI .

BLOOD, 2003, 102 (07) :2670-2677

[10]

Oxidation of high density lipoproteins -: I.: Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by α-tocopherol [J].

Garner, B ;

Witting, PK ;

Waldeck, AR ;

Christison, JK ;

Raftery, M ;

Stocker, P .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (11) :6080-6087

← 1 2 3 4 5 →